64 results
Page 2 of 4
CORRESP
eezt dfj6otw
29 Jun 22
Correspondence with SEC
12:00am
8-K
EX-4.3
95ufi6k5q 3mh
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
424B5
jqd08eftorvkgyb
14 Mar 22
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
x4xrd p98l
4 May 21
Agile Therapeutics Reports First Quarter 2021 Financial Results
4:10pm
8-K
EX-99.1
r5yn36x8z ga
1 Mar 21
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
cn6dt8kn9brem
26 Feb 20
Regulation FD Disclosure
4:29pm
8-K
EX-10.1
30tustaqe9sarw06htt
12 Feb 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-99.1
vys5fge np8fq
8 Jan 20
Results of Operations and Financial Condition
4:31pm